LOCUS       NM_001302690            1244 bp    mRNA    linear   PRI 21-FEB-2021
DEFINITION  Homo sapiens apolipoprotein E (APOE), transcript variant 4, mRNA.
ACCESSION   NM_001302690
VERSION     NM_001302690.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 1244)
  AUTHORS   Wang C, Zhang M, Garcia G Jr, Tian E, Cui Q, Chen X, Sun G, Wang J,
            Arumugaswami V and Shi Y.
  TITLE     ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular
            Response
  JOURNAL   Cell Stem Cell 28 (2), 331-342 (2021)
   PUBMED   33450186
  REMARK    GeneRIF: ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and
            Cellular Response.
REFERENCE   2  (bases 1 to 1244)
  AUTHORS   Wang N, Liu Q, Liu H, Cong X, Yang H, Yu Y, Cao Y and Ma L.
  TITLE     Association of Apolipoprotein E Polymorphisms and Risks of Ischemic
            Stroke in Chinese Patients with Type 2 Diabetes Mellitus
  JOURNAL   J Diabetes Res 2021, 8816996 (2021)
   PUBMED   33490286
  REMARK    GeneRIF: Association of Apolipoprotein E Polymorphisms and Risks of
            Ischemic Stroke in Chinese Patients with Type 2 Diabetes Mellitus.
            Publication Status: Online-Only
REFERENCE   3  (bases 1 to 1244)
  AUTHORS   Serrano-Pozo A, Das S and Hyman BT.
  TITLE     APOE and Alzheimer's disease: advances in genetics,
            pathophysiology, and therapeutic approaches
  JOURNAL   Lancet Neurol 20 (1), 68-80 (2021)
   PUBMED   33340485
  REMARK    GeneRIF: APOE and Alzheimer's disease: advances in genetics,
            pathophysiology, and therapeutic approaches.
            Review article
            Erratum:[Lancet Neurol. 2021 Feb;20(2):e2. PMID: 33484655]
REFERENCE   4  (bases 1 to 1244)
  AUTHORS   Colovati MES, Novais IP, Zampol M, Mendes GD, Cernach MCS and
            Zanesco A.
  TITLE     Interaction between physical exercise and APOE gene polymorphism on
            cognitive function in older people
  JOURNAL   Braz J Med Biol Res 54 (2), e10098 (2020)
   PUBMED   33331535
  REMARK    GeneRIF: Interaction between physical exercise and APOE gene
            polymorphism on cognitive function in older people.
            Review article
            Publication Status: Online-Only
REFERENCE   5  (bases 1 to 1244)
  AUTHORS   Greyshock,N., Guyton,J.R., Sebastian,S. and Okorodudu,D.
  TITLE     APOE p.Leu167del-Related Lipid Disorders - RETIRED CHAPTER, FOR
            HISTORICAL REFERENCE ONLY
  JOURNAL   (in) Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G
            and Amemiya A (Eds.);
            GENEREVIEWS((R));
            (1993)
   PUBMED   24921113
REFERENCE   6  (bases 1 to 1244)
  AUTHORS   Bird,T.D.
  TITLE     Alzheimer Disease Overview
  JOURNAL   (in) Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G
            and Amemiya A (Eds.);
            GENEREVIEWS((R));
            (1993)
   PUBMED   20301340
REFERENCE   7  (bases 1 to 1244)
  AUTHORS   McLean,J.W., Elshourbagy,N.A., Chang,D.J., Mahley,R.W. and
            Taylor,J.M.
  TITLE     Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing
            of a new variant
  JOURNAL   J Biol Chem 259 (10), 6498-6504 (1984)
   PUBMED   6327682
REFERENCE   8  (bases 1 to 1244)
  AUTHORS   Utermann,G., Pruin,N. and Steinmetz,A.
  TITLE     Polymorphism of apolipoprotein E. III. Effect of a single
            polymorphic gene locus on plasma lipid levels in man
  JOURNAL   Clin Genet 15 (1), 63-72 (1979)
   PUBMED   759055
REFERENCE   9  (bases 1 to 1244)
  AUTHORS   Innerarity,T.L., Mahley,R.W., Weisgraber,K.H. and Bersot,T.P.
  TITLE     Apoprotein (E--A-II) complex of human plasma lipoproteins. II.
            Receptor binding activity of a high density lipoprotein subfraction
            modulated by the apo(E--A-II) complex
  JOURNAL   J Biol Chem 253 (17), 6289-6295 (1978)
   PUBMED   210175
REFERENCE   10 (bases 1 to 1244)
  AUTHORS   Weisgraber,K.H. and Mahley,R.W.
  TITLE     Apoprotein (E--A-II) complex of human plasma lipoproteins. I.
            Characterization of this mixed disulfide and its identification in
            a high density lipoprotein subfraction
  JOURNAL   J Biol Chem 253 (17), 6281-6288 (1978)
   PUBMED   210174
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from CA771535.1, HY074888.1 and
            BC003557.1.
            On Aug 13, 2020 this sequence version replaced NM_001302690.1.
            
            Summary: The protein encoded by this gene is a major apoprotein of
            the chylomicron. It binds to a specific liver and peripheral cell
            receptor, and is essential for the normal catabolism of
            triglyceride-rich lipoprotein constituents. This gene maps to
            chromosome 19 in a cluster with the related apolipoprotein C1 and
            C2 genes. Mutations in this gene result in familial
            dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III),
            in which increased plasma cholesterol and triglycerides are the
            consequence of impaired clearance of chylomicron and VLDL remnants.
            [provided by RefSeq, Jun 2016].
            
            Transcript Variant: This variant (4) contains an alternate 5'
            terminal exon, and it thus differs in the 5' UTR and initiates
            translation at a downstream in-frame start codon, compared to
            variant 1. The encoded isoform (b) is shorter at the N-terminus,
            compared to isoform a. Variants 2, 3, 4 and 5 all encode isoform b.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: HY074888.1, DRR138522.806557.1
                                           [ECO:0000332]
            ##Evidence-Data-END##
            COMPLETENESS: complete on the 3' end.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-8                 CA771535.1         42-49
            9-97                HY074888.1         9-97
            98-124              CA771535.1         139-165
            125-1244            BC003557.1         23-1142
FEATURES             Location/Qualifiers
     source          1..1244
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="19"
                     /map="19q13.32"
     gene            1..1244
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="apolipoprotein E"
                     /db_xref="GeneID:348"
                     /db_xref="HGNC:HGNC:613"
                     /db_xref="MIM:107741"
     exon            1..124
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    79..81
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="upstream in-frame stop codon"
     exon            125..190
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     CDS             148..1101
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="isoform b precursor is encoded by transcript
                     variant 4; apolipoprotein E3"
                     /codon_start=1
                     /product="apolipoprotein E isoform b precursor"
                     /protein_id="NP_001289619.1"
                     /db_xref="CCDS:CCDS12647.1"
                     /db_xref="GeneID:348"
                     /db_xref="HGNC:HGNC:613"
                     /db_xref="MIM:107741"
                     /translation="MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRW
                     ELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTP
                     VAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLR
                     KLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAG
                     QPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQ
                     ARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH"
     sig_peptide     148..201
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="COORDINATES: ab initio prediction:SignalP:4.0"
     mat_peptide     202..1098
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /product="Apolipoprotein E. /id=PRO_0000001987"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1)"
     misc_feature    223..225
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="O-linked (GalNAc...) threonine.
                     /evidence=ECO:0000269|PubMed:23234360; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); glycosylation site"
     misc_feature    253..255
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="O-linked (GalNAc...) threonine.
                     /evidence=ECO:0000269|PubMed:23234360; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); glycosylation site"
     misc_feature    385..912
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1);
                     Region: 8 X 22 AA approximate tandem repeats"
     misc_feature    424..426
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="N-linked (Glc) (glycation) lysine.
                     /evidence=ECO:0000269|PubMed:10452964; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); glycosylation site"
     misc_feature    586..588
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="Phosphoserine, by FAM20C.
                     /evidence=ECO:0000244|PubMed:24275569,
                     ECO:0000269|PubMed:26091039; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); phosphorylation site"
     misc_feature    619..651
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1);
                     Region: LDL and other lipoprotein receptors binding.
                     /evidence=ECO:0000269|PubMed:20030366,
                     ECO:0000269|PubMed:2063194"
     misc_feature    631..642
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1);
                     Region: Heparin-binding.
                     /evidence=ECO:0000269|PubMed:3947350"
     misc_feature    775..1017
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1);
                     Region: Lipid-binding and lipoprotein association.
                     /evidence=ECO:0000269|PubMed:2280190,
                     ECO:0000269|PubMed:8071364"
     misc_feature    781..783
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="O-linked (GalNAc...) threonine.
                     /evidence=ECO:0000269|PubMed:19838169,
                     ECO:0000269|PubMed:2498325; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); glycosylation site"
     misc_feature    832..855
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1);
                     Region: Heparin-binding.
                     /evidence=ECO:0000269|PubMed:3947350"
     misc_feature    943..1098
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1);
                     Region: Homooligomerization.
                     /evidence=ECO:0000269|PubMed:8340399"
     misc_feature    979..1017
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="propagated from UniProtKB/Swiss-Prot (P02649.1);
                     Region: Specificity for association with VLDL.
                     /evidence=ECO:0000269|PubMed:8071364"
     misc_feature    1066..1068
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="O-linked (GalNAc...) threonine.
                     /evidence=ECO:0000269|PubMed:19838169; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); glycosylation site"
     misc_feature    1069..1071
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="O-linked (GalNAc...) serine.
                     /evidence=ECO:0000269|PubMed:19838169,
                     ECO:0000269|PubMed:20511397; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); glycosylation site"
     misc_feature    1087..1089
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="O-linked (GalNAc...) serine.
                     /evidence=ECO:0000269|PubMed:23234360; propagated from
                     UniProtKB/Swiss-Prot (P02649.1); glycosylation site"
     exon            191..383
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     exon            384..1244
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     regulatory      1219..1224
                     /regulatory_class="polyA_signal_sequence"
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="hexamer: AATAAA"
     polyA_site      1244
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="major polyA site"
ORIGIN      
        1 ggatggggag ataagagaag accaggaggg agttaaatag ggaatgggtt gggggcggct
       61 tggtaaatgt gctgggatta ggctgttgca gataatgcaa caaggcttgg aaggctaacc
      121 tgggactggc caatcacagg caggaagatg aaggttctgt gggctgcgtt gctggtcaca
      181 ttcctggcag gatgccaggc caaggtggag caagcggtgg agacagagcc ggagcccgag
      241 ctgcgccagc agaccgagtg gcagagcggc cagcgctggg aactggcact gggtcgcttt
      301 tgggattacc tgcgctgggt gcagacactg tctgagcagg tgcaggagga gctgctcagc
      361 tcccaggtca cccaggaact gagggcgctg atggacgaga ccatgaagga gttgaaggcc
      421 tacaaatcgg aactggagga acaactgacc ccggtggcgg aggagacgcg ggcacggctg
      481 tccaaggagc tgcaggcggc gcaggcccgg ctgggcgcgg acatggagga cgtgtgcggc
      541 cgcctggtgc agtaccgcgg cgaggtgcag gccatgctcg gccagagcac cgaggagctg
      601 cgggtgcgcc tcgcctccca cctgcgcaag ctgcgtaagc ggctcctccg cgatgccgat
      661 gacctgcaga agcgcctggc agtgtaccag gccggggccc gcgagggcgc cgagcgcggc
      721 ctcagcgcca tccgcgagcg cctggggccc ctggtggaac agggccgcgt gcgggccgcc
      781 actgtgggct ccctggccgg ccagccgcta caggagcggg cccaggcctg gggcgagcgg
      841 ctgcgcgcgc ggatggagga gatgggcagc cggacccgcg accgcctgga cgaggtgaag
      901 gagcaggtgg cggaggtgcg cgccaagctg gaggagcagg cccagcagat acgcctgcag
      961 gccgaggcct tccaggcccg cctcaagagc tggttcgagc ccctggtgga agacatgcag
     1021 cgccagtggg ccgggctggt ggagaaggtg caggctgccg tgggcaccag cgccgcccct
     1081 gtgcccagcg acaatcactg aacgccgaag cctgcagcca tgcgacccca cgccaccccg
     1141 tgcctcctgc ctccgcgcag cctgcagcgg gagaccctgt ccccgcccca gccgtcctcc
     1201 tggggtggac cctagtttaa taaagattca ccaagtttca cgca
//

